For subscribers

China is becoming a pharmaceutical powerhouse

China’s biotech sector has established a bright future by focusing not on breakthrough cures and treatments, but on speed and efficiency.

Sign up now: Get ST's newsletters delivered to your inbox

epa10513290 A woman buys medicines at a pharmacy in Shanghai, China, 10 March 2023. Authorities from China's Xi'an city, the capital of the Shaanxi province, published an emergency notice earlier in the week alerting of the potential suspension of business activities and schools over a surge in H1N1 influenza cases across the country. The emergency plan may include temporary lockdowns, the enforcement of quarantine measures, and work and production suspensions in the affected areas, depending on the severity of the outbreak.  EPA-EFE/ALEX PLAVEVSKI

In its quest to dethrone American dominance in biotech, China isn’t necessarily trying to beat America at its own game, says the writer.

PHOTO: EPA-EFE

Jacob Dreyer

Follow topic:

Just outside of Shanghai, in the city of Wuxi, China is building its future of medicine – a booming biotechnology hub of factories and laboratories where global pharmaceutical firms can develop and manufacture drugs faster and cheaper than anywhere else.

Amid the Trump administration’s tariffs on China, I figured manufacturing hubs like this one would be racked with anxiety. But when I visited Wuxi in April, government officials insisted that its research hub was flourishing. They were proud to tell me about its superstar labs and companies that are continuing to thrive.

See more on